Literature DB >> 26558733

Cryptococcal antigen screening in HIV-infected adults: let's get straight to the point.

Rachel M Wake1, Deborah K Glencross, Charlotte Sriruttan, Tom S Harrison, Nelesh P Govender.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26558733     DOI： 10.1097/QAD.0000000000000967

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  4 in total

1.  Cryptococcal-related Mortality Despite Fluconazole Preemptive Treatment in a Cryptococcal Antigen Screen-and-Treat Program.

Authors:  Rachel M Wake; Nelesh P Govender; Tanvier Omar; Carolina Nel; Ahmad Haeri Mazanderani; Aaron S Karat; Nazir A Ismail; Caroline T Tiemessen; Joseph N Jarvis; Thomas S Harrison
Journal:  Clin Infect Dis       Date:  2020-04-10       Impact factor: 9.079

Review 2.  Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.

Authors:  Sarah Lofgren; Mahsa Abassi; Joshua Rhein; David R Boulware
Journal:  Expert Rev Anti Infect Ther       Date:  2017-02-09       Impact factor: 5.091

3.  Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa.

Authors:  Bruce A Larson; Peter C Rockers; Rachael Bonawitz; Charlotte Sriruttan; Deborah K Glencross; Naseem Cassim; Lindi M Coetzee; Gregory S Greene; Tom M Chiller; Snigdha Vallabhaneni; Lawrence Long; Craig van Rensburg; Nelesh P Govender
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

4.  Extent of Lung Involvement and Serum Cryptococcal Antigen Test in Non-Human Immunodeficiency Virus Adult Patients with Pulmonary Cryptococcosis.

Authors:  Tao Zhu; Wan-Ting Luo; Gui-Hua Chen; Yue-Sheng Tu; Shuo Tang; Huo-Jin Deng; Wei Xu; Wei Zhang; Di Qi; Dao-Xin Wang; Chang-Yi Li; He Li; Yan-Qiao Wu; Shen-Jin Li
Journal:  Chin Med J (Engl)       Date:  2018-09-20       Impact factor: 2.628
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.